New drug nezavist takes first step toward helping heavy drinkers
NCT ID NCT06633562
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 27 times
Summary
This early-stage study tests whether Nezavist is safe for people and how the body processes it. Thirty-two healthy adults will receive either the drug or a placebo. The results will guide future research on using Nezavist to help people drink less alcohol.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The Altman Clinical and Translational Research Institute
La Jolla, California, 92037, United States
Conditions
Explore the condition pages connected to this study.